Myocardial ischemia in Wegener's granulomatosis: Coronary atherosclerosis versus vasculitis

Open Cardiovascular Medicine Journal

Volumn 4, Issue SPEC. ISSUE 1, 2010, Pages 57-62

  Cocco, Giuseppe ^a   Gasparyan, Armen Yuri ^b  

^a Cardiology Office   (Switzerland)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Coronary arteries; Vasculitis; Wegener's granulomatosis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; ANTISTREPTOLYSIN; AZATHIOPRINE; C REACTIVE PROTEIN; CEFUROXIME; CLOPIDOGREL; CYCLOPHOSPHAMIDE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; GENTAMICIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTHROPATHY; ARTICLE; BONE MARROW BIOPSY; BRONCHOSCOPY; CARDIOMEGALY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; EOSINOPHILIA; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLU LIKE SYNDROME; HAND SWELLING; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE EJECTION FRACTION; HISTIOCYTE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOCLASTIC VASCULITIS; LIMB SWELLING; LUNG BIOPSY; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; MAINTENANCE DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUSITIS; PARESTHESIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; SYSTOLIC HEART MURMUR; THORAX RADIOGRAPHY; VISUAL IMPAIRMENT; WEGENER GRANULOMATOSIS; WRIST DISEASE; WRIST TENDERNESS;

EID: 78249242756     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401004010057     Document Type: Article

References (67)

1. Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28: 1797-1804.
2. Gasparyan AY, Ugurlucan M. The emerging issue of cardiovascu-lar involvement in familial Mediterranean fever. Arch Med Sci 2008; 4: 465-467.
3. Kaplan MJ. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol 2009; 5: 208-217.
4. Trifiletti A, Scamardi R, Bagnato GF, Gaudio A. Hemostatic changes in vasculitides. Thromb Res 2009; 124: 252-255.
5. Mukhtyar C, Brogan P, Luqmani R. Cardiovascular involvement in primary systemic vasculitis. Best Pract Res Clin Rheumatol 2009; 23: 419-428.
6. Turesson C, Jacobsson LT, Matteson EL. Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Manag 2008; 4: 605-614.
7. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229.
8. Guillevin L. Vasculopathy and pulmonary arterial hypertension. Rheumatology (Oxford) 2009; 48(Suppl 3): 54-57.
9. Turesson C, Matteson EL. Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 35-40.
10. Neumann T, Manger B, Schmid M, et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 2009; 88: 236-243.
11. Pereira RM, de Carvalho JF, Bonfá E. Metabolic syndrome in rheumatological diseases. Autoimmun Rev 2009; 8: 415-419.
12. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther 2008; 10: 224.
13. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, et al. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil 2009; 16: 188-194.
14. Tanay A, Leibovitz E, Frayman A, Zimlichman R, Shargorodsky M, Gavish D. Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treat-ment. Ann N Y Acad Sci 2007; 1108: 24-34.
15. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 2003; 42: 292-7.
16. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lu-pus erythematosus. Ann Rheum Dis 2003; 62: 1071-1077.
17. Cortes S, Chambers S, Jerónimo A, Isenberg D. Diabetes mellitus complicating systemic lupus erythematosus-analysis of the UCL lupus cohort and review of the literature. Lupus 2008; 17: 977-980.
18. Gazi IF, Boumpas DT, Mikhailidis DP, Ganotakis ES. Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin Exp Rheumatol 2007; 25: 102-111.
19. Tziomalos K, Tziomalos K, Sivanadarajah N, Mikhailidis DP, Boumpas DT, Seifalian AM. Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk? Clin Exp Rheumatol 2008; 26: 1134-1145.
20. van Leuven SI, Kastelein JJ, D'Cruz DP, Hughes GR, Stroes ES. Atherogenesis in rheumatology. Lupus 2006; 15: 117-121.
21. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008; 121 (10 Suppl 1): S3-8.
22. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008; 121 (10 Suppl 1): S21-31.
23. Dhawan SS, Quyyumi AA. Rheumatoid arthritis and cardiovascu-lar disease. Curr Atheroscler Rep 2008; 10: 128-133.
24. Montecucco F, Mach F. Common inflammatory mediators orches-trate pathophysiological processes in rheumatoid arthritis and athe-rosclerosis. Rheumatology (Oxford) 2009; 48: 11-22.
25. Haque S, Mirjafari H, Bruce IN. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr Opin Lipidol 2008; 19: 338-343.
26. Ridker PM. Testing the inflammatory hypothesis of atherothrom-bosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). J Thromb Haemost 2009; 7(Suppl 1): 332-339.
27. Suzuki A, Miyagawa-Tomita S, Komatsu K, et al. Immunohisto-chemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int 2004; 46: 590-596.
28. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Behçet's Syndrome. Semin Arthritis Rheum 2008; 38: 1-12.
29. Fukazawa R, Ogawa S. Long-term prognosis of patients with Ka-wasaki disease: at risk for future atherosclerosis? J Nippon Med Sch 2009; 76: 124-133.
30. Sangle SR, Davies RJ, Mora M, Baron MA, Hughes GR, D'Cruz DP. Ankle-brachial pressure index: a simple tool for assessing car-diovascular risk in patients with systemic vasculitis. Rheumatology (Oxford) 2008; 47: 1058-1060.
31. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 2008; 118: 1276-1284.
32. Li JJ, Li Z, Li J. Is any link between inflammation and coronary artery ectasia? Med Hypotheses 2007; 69: 678-683.
33. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. 1973. Medicine (Balti-more) 1994; 73: 315-324
34. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
35. Yi ES, Colby TV. Wegener's granulomatosis. Semin Diagn Pathol 2001; 18: 34-46.
36. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-1032.
37. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-498.
38. Ohkawa S, Miyao M, Chida K, et al. Extensive involvement of the myocardium and the cardiac conduction system in a case of Wegener's granulomatosis. Jpn Heart J 1999; 40: 509-515.
39. Khurana C, Mazzone P, Mandell B. Khurana C, Mazzone P, Mandell B. New onset left bundle branch block with right axis deviation in a patient with Wegener's granulomatosis. J Electrocardiol 2000; 33: 199-201.
40. Suleymenlar G, Sarikaya M, Sari R, Tuncer M, Sevinc A. Complete heart block in a patient with Wegener's granulomatosis in remission--a case report. Angiology 2002; 53: 337-340.
41. Kouba DJ, Kirsch DG, Mimouni D, Nousari CH. Wegener's granu-lomatosis with cardiac involvement masquerading as Lyme disease. Clin Exp Rheumatol 2003; 21: 647-649.
42. Ghaussy NO, Du Clos TW, Ashley PA. Limited Wegener's granu-lomatosis presenting with complete heart block. Scand J Rheumatol 2004; 33: 115-118.
43. Lim HE, Lee YH, Ahn JC. Wegener's granulomatosis with pro-gressive conduction disturbances and atrial fibrillation. Heart 2007; 93: 777.
44. Anthony DD, Askari AD, Wolpaw T, McComsey G. Wegener granulomatosis simulating bacterial endocarditis. Arch Intern Med 1999; 159: 1807-1810.
45. Leff RD, Hellman RN, Mullany CJ. Acute aortic insufficiency associated with Wegener granulomatosis. Mayo Clin Proc 1999; 74: 897-899.
46. Korantzopoulos P, Papaioannides D, Siogas K. The heart in Wegener's granulomatosis. Cardiology 2004; 102: 7-10.
47. Herbst A, Padilla MT, Prasad AR, Morales MC, Copeland JG. Cardiac Wegener's granulomatosis masquerading as left atrial myxoma. Ann Thorac Surg 2003; 75: 1321-1323.
48. To A, De Zoysa J, Christiansen JP. Cardiomyopathy associated with Wegener's granulomatosis. Heart 2007; 93: 984.
49. De Bandt M, Meyer O, Dacosta L, Elbim C, Pasquier C. Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane. Clin Exp Immunol 1999; 115: 362-368.
50. Nienhuis HL, de Leeuw K, Smit AJ, et al. Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis. J Rheumatol 2007; 34: 1875-1881.
51. Shitrit D, Shitrit AB, Starobin D, et al. Large vessel aneurysms in Wegener's granulomatosis. J Vasc Surg 2002; 36: 856-858.
52. Frauenfelder T, Wildermuth S, Marincek B, Boehm T. Nontrau-matic emergent abdominal vascular conditions: advantages of multi-detector row CT and three-dimensional imaging. Radiographics 2004; 24: 481-496.
53. Bessias N, Moulakakis KG, Lioupis C, et al. Wegener's granulomatosis presenting during pregnancy with acute limb ischemia. J Vasc Surg 2005; 42: 800-4.
54. Arlet JB, Le Thi Huong D, Marinho A, Cluzel P, Wechsler B, Piette JC. Arterial aneurysms in Wegener's granulomatosis: case report and literature review. Semin Arthritis Rheum 2008; 37: 265-268.
55. Maia M, Brandão P, Monteiro P, et al. Upper limb ischemia in a patient with Wegener's granulomatosis. Interact Cardiovasc Thorac Surg 2008; 7: 1137-1140.
56. Mavrogeni S, Manoussakis MN, Karagiorga TC, et al. Detection of coronary artery lesions and myocardial necrosis by magnetic reso-nance in systemic necrotizing vasculitides. Arthritis Rheum 2009; 61: 1121-1129.
57. Neynaber S, Mistry-Burchardi N, Rust C, et al. PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol 2008; 88: 594-6.
58. Morbini P, Dal Bello B, Arbustini E. Coronary artery inflammation and thrombosis in Wegener's granulomatosis-polyarteritis nodosa overlap syndrome. G Ital Cardiol 1998; 28: 377-382.
59. Parry SD, Clark DM, Campbell J. Coronary arteritis in Wegener's granulomatosis causing fatal myocardial infarction. Hosp Med 2000; 61: 284-5.
60. Seo P. Wegener's granulomatosis: managing more than inflammation. Curr Opin Rheumatol 2008; 20: 10-16.
61. de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M. Accelerated atherosclerosis in patients with Wegener's granu-lomatosis. Ann Rheum Dis 2005; 64: 753-9.
62. Gasparyan AY. The use of carotid artery ultrasonography in different clinical conditions. Open Cardiovasc Med J 2009; 3: 78-80.
63. Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B. Increased morbidity from ischemic heart dis-ease in patients with Wegener's granulomatosis. Arthritis Rheum 2009; 60: 1187-1192.
64. Papo T, Piette JC, Laraki R, Bletry O, Huong DL, Godeau P. Silent myocardial infarction in Wegener's granulomatosis. Ann Rheum Dis 1995; 54: 233-4.
65. Lawson TM, Williams BD. Silent myocardial infarction in Wegener's granulomatosis. Br J Rheumatol 1996; 35: 188-191.
66. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-1107.
67. Lazarus MN, Khurana R, Sethi AS, Naughton MA. Wegener's granulomatosis presenting with an acute ST-elevation myocardial infarct (STEMI). Rheumatology (Oxford) 2006; 45: 916-968.